Aperio Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.84M | Buy |
|
|||||
|
2020
Q3 | $1.59M | Sell |
|
|||||
|
2020
Q2 | $2.11M | Sell |
|
|||||
|
2020
Q1 | $1.6M | Buy |
|
|||||
|
2019
Q4 | $2.2M | Buy |
|
|||||
|
2019
Q3 | $2.02M | Sell |
|
|||||
|
2019
Q2 | $2.43M | Buy |
|
|||||
|
2019
Q1 | $2.64M | Sell |
|
|||||
|
2018
Q4 | $2.97M | Sell |
|
|||||
|
2018
Q3 | $6.66M | Buy |
|
|||||
|
2018
Q2 | $4.94M | Sell |
|
|||||
|
2018
Q1 | $4.03M | Buy |
|
|||||
|
2017
Q4 | $3.28M | Buy |
|
|||||
|
2017
Q3 | $2.73M | Buy |
|
|||||
|
2017
Q2 | $2.37M | Buy |
|
|||||
|
2017
Q1 | $976K | Buy |
|
|||||
|
2016
Q4 | $711K | Sell |
|
|||||
|
2016
Q3 | $831K | Buy |
|
|||||
|
2016
Q2 | $806K | Buy |
|
|||||
|
2016
Q1 | $625K | Buy |
|
|||||
|
2015
Q4 | $436K | Buy |
|
|||||
|
2015
Q3 | $286K | Buy |
|
|||||
|
2015
Q2 | $315K | Buy |
|
|||||
|
2015
Q1 | $210K | Buy |
|